Caregiver burden and neuropsychiatric symptoms in older adults with cognitive impairment: the Aging, Demographics, and Memory Study (ADAMS).

TitleCaregiver burden and neuropsychiatric symptoms in older adults with cognitive impairment: the Aging, Demographics, and Memory Study (ADAMS).
Publication TypeJournal Article
Year of Publication2011
AuthorsOkura, T, Langa, KM
JournalAlzheimer Dis Assoc Disord
Volume25
Issue2
Pagination116-21
Date Published2011 Apr-Jun
ISSN Number1546-4156
KeywordsAged, Aged, 80 and over, Caregivers, Cognition Disorders, Cost of Illness, Cross-Sectional Studies, Female, Humans, Male, Neuropsychological tests
Abstract

OBJECTIVES: To estimate the quantity of informal care associated with neuropsychiatric symptoms in older adults with cognitive impairment.

DESIGN: Cross-sectional analysis.

SETTING: The Aging, Demographics, and Memory Study.

PARTICIPANTS: A sample (n=450) of adults aged 71 years and older with cognitive impairment drawn form the Health and Retirement Study.

MEASUREMENTS: The presence of neuropsychiatric symptoms (delusions, hallucinations, agitation, depression, apathy, elation, anxiety, disinhibition, irritation, and aberrant motor behaviors) was identified using the neuropsychiatric inventory. Cognitive category [normal, cognitive impairment without dementia (CIND), or dementia] was assigned by a consensus panel. The hours per week of active help and supervision were ascertained by informant questionnaire.

RESULTS: Among older adults with CIND or dementia, those with no neuropsychiatric symptoms received an average of 10.2 hours of active help and 10.9 hours of supervision per week from informal caregivers. Those with 1 or 2 neuropsychiatric symptoms received an additional 10.0 hours of active help and 12.4 hours of supervision per week, while those with 3 or more symptoms received an additional 18.2 hours of active help and 28.7 hours of supervision per week (P<0.001). The presence of irritation (14.7 additional hours) was associated with the greatest number of additional hours of active help. The presence of aberrant motor behaviors (17.7 additional hours) and disinhibition (17.5 additional hours) were associated with the greatest number of additional hours of supervision.

CONCLUSIONS: Neuropsychiatric symptoms among those with CIND or dementia are associated with a significant increase in the provision of informal care. This care represents a significant time commitment for families and a significant economic cost to society.

Notes

Okura, Toru Langa, Kenneth M R01 AG027010/AG/NIA NIH HHS/United States R01 AG030155-01/AG/NIA NIH HHS/United States R01 AG030155-02/AG/NIA NIH HHS/United States R01 AG030155-03/AG/NIA NIH HHS/United States R01 AG030155-04/AG/NIA NIH HHS/United States R01 AG030155-05/AG/NIA NIH HHS/United States U01 AG09740/AG/NIA NIH HHS/United States Research Support, N.I.H., Extramural United States Alzheimer disease and associated disorders Nihms259646 Alzheimer Dis Assoc Disord. 2011 Apr-Jun;25(2):116-21.

DOI10.1097/WAD.0b013e318203f208
User Guide Notes

http://www.ncbi.nlm.nih.gov/pubmed/21192239?dopt=Abstract

Endnote Keywords

Aged, 80 and over/Caregivers/ statistics/Caregivers/ statistics/numerical data/Cognition Disorders/ psychology/Cognition Disorders/ psychology/Cost of Illness/Cross-Sectional Studies/Female/Humans/Neuropsychological Tests

Endnote ID

62784

Alternate JournalAlzheimer Dis Assoc Disord
Citation Key7658
PubMed ID21192239
PubMed Central IDPMC3100441
Grant ListR01 AG027010-01 / AG / NIA NIH HHS / United States
R01 AG027010-03 / AG / NIA NIH HHS / United States
U01 AG09740 / AG / NIA NIH HHS / United States
R01 AG027010-02S1 / AG / NIA NIH HHS / United States
R01 AG030155-01 / AG / NIA NIH HHS / United States
R01 AG027010-02 / AG / NIA NIH HHS / United States
R01 AG030155-02 / AG / NIA NIH HHS / United States
U01 AG009740 / AG / NIA NIH HHS / United States
R01 AG030155 / AG / NIA NIH HHS / United States
R01 AG030155-05 / AG / NIA NIH HHS / United States
R01 AG030155-04 / AG / NIA NIH HHS / United States
R01 AG030155-03 / AG / NIA NIH HHS / United States
R01 AG027010 / AG / NIA NIH HHS / United States